The University of Ghana Medical School (UGMS) has refuted claims circulating on social media that its researchers have created a cassava-based compound that can reverse Type 2 diabetes.
In a statement released on Monday, January 19, 2026, UGMS clarified that it has not engaged in any research that would lead to the creation of such a compound, referred to in the publication as “cassavarin,” and has not isolated any substance by that name.
The School further indicated that it has not conducted any clinical trials related to the circulating claims, labeling reports of regulatory approvals, pharmaceutical lawsuits, and licensing agreements as completely fabricated.
UGMS emphasized its commitment to maintaining the highest standards of scientific integrity and ethical research practices, urging the public to ignore the misleading publication.
Members of the public are advised to depend exclusively on information disseminated through official University of Ghana channels for accurate and verified updates regarding research activities.
The University of Ghana Medical School stated that it firmly dissociates itself from the misinformation and is taking necessary measures to address the issue.
